Showing results (351-360 of 520) with videos related to

Sort By:
Pageof 52
Optics Express|April 15, 2009
Luminescence properties of a Fibonacci photonic quasicrystalV Passias, N V Valappil, Z Shi, et al.
American Journal of Obstetrics and Gynecology|December 1, 1987
The effect of insulin on aromatase activity in isolated human endometrial glands and stromaJ F Randolph, S Kipersztok, J W Ayers, et al.
Nature Nanotechnology|August 14, 2025
Efficient and tunable photochemical charge transfer via long-lived Bloch surface wave polaritonsKamyar Rashidi, Evripidis Michail, Bernardo Salcido-Santacruz, et al.
Abdominal Radiology (New York)|September 16, 2022
Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysisSeyed Behzad Jazayeri, Hojat Dehghanbanadaki, Mahdie Hosseini, et al.
Journal of Applied Clinical Medical Physics|February 27, 2024
MRI-based radiomic features for identifying recurrent prostate cancer after proton radiation therapyKazim Z Gumus, Samuel Serrano Contreras, Mohammed Al-Toubat, et al.
Journal of Clinical Pharmacology|December 19, 2018
Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology StorehouseMohamad Shebley, Rajeev M Menon, John P Gibbs, et al.
The Journal of Urology|November 1, 1991
A new model of nephrolithiasis involving tubular dysfunction/injuryS Kumar, D Sigmon, T Miller, et al.
Drug Metabolism and Drug Interactions|January 1, 1994
Effect of environmental pollutants on hepatocellular function in rats: 3-methylcholanthrene and Aroclor-1254M S Dhami, M Menon, R Aliling, et al.
Journal of Clinical Pharmacology|April 17, 2019
An Integrated Population Pharmacokinetic Model Versus Individual Models of Depatuxizumab Mafodotin, an Anti-EGFR Antibody Drug Conjugate, in Patients With Solid Tumors Likely to Overexpress EGFRRajendar K Mittapalli, Sven Stodtmann, Anna Friedel, et al.
Journal of Clinical Pharmacology|August 23, 2022
Impact of Multiple Concomitant CYP3A Inhibitors on Venetoclax Pharmacokinetics: A PBPK and Population PK-Informed AnalysisDwaipayan Mukherjee, Deanna J Brackman, Ahmed A Suleiman, et al.
Pageof 52